NBC Securities’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.13K Hold
231
﹤0.01% 2164
2026
Q1
$1.38K Hold
231
﹤0.01% 2379
2025
Q4
$1.66K Sell
231
-7,976
-97% -$63K ﹤0.01% 2452
2025
Q3
$87.7K Sell
8,207
-668
-8% -$6.56K 0.01% 1123
2025
Q2
$85K Sell
8,875
-34
-0.4% -$351 0.01% 1118
2025
Q1
$132K Buy
8,909
+8,901
+111,263% +$137K 0.01% 904
2024
Q4
$125 Sell
8
-8,393
-100% -$137K 0.01% 881
2024
Q3
$160K Sell
8,401
-69
-0.8% -$1.43K 0.01% 852
2024
Q2
$175K Buy
8,470
+1,390
+20% +$27.6K 0.02% 794
2024
Q1
$133K Buy
7,080
+65
+0.9% +$1.11K 0.01% 875
2023
Q4
$101K Sell
7,015
-435
-6% -$5.92K 0.01% 944
2023
Q3
$129K Buy
+7,450
New +$155K 0.01% 840

Other funds holding OGN

NBC Securities's OGN Position: Q2 2026 in Review

NBC Securities held its Organon & Co (OGN) position steady in Q2 2026 at 231 shares worth $3.13K. The position accounts for ﹤0.01% of the portfolio, ranked #2164.

NBC Securities first reported a position in OGN in Q3 2023 and has held it in 12 quarters since. The position peaked at $175K in Q2 2024. 107 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • NBC Securities held 231 shares of Organon & Co worth $3.13K as of Q2 2026.
  • NBC Securities left its Organon & Co share count unchanged in Q2 2026.
  • Organon & Co made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #2164 holding.
  • NBC Securities first reported a position in Organon & Co in Q3 2023 and has held it in 12 quarters since.
  • NBC Securities's Organon & Co position peaked at $175K in Q2 2024.
  • 107 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.